Search research articles
Contact Us
Filters
Showing results (41-50 of 77) with videos related to
Page
of 8
Sort By:
Plos One
|
May 17, 2014
The Thoc1 encoded ribonucleoprotein is required for myeloid progenitor cell homeostasis in the adult mouse
Laura Pitzonka, Sumana Ullas, Meenalakshmi Chinnam, et al.
Cancer Cell International
|
January 8, 2026
Modeling primary immunotherapy resistance in metastatic bladder cancer: a syngeneic, bioluminescent mouse model
Dongbo Xu, Justine J Jacob, Kyle Wieczorek, et al.
The Prostate
|
May 27, 2016
Generation of a C57BL/6 MYC-Driven Mouse Model and Cell Line of Prostate Cancer
Leigh Ellis, ShengYu Ku, Qiuhui Li, et al.
Cancers
|
March 19, 2020
Vitamin D3 Metabolites Demonstrate Prognostic Value in <i>EGFR</i>-Mutant Lung Adenocarcinoma and Can be Deployed to Oppose Acquired Therapeutic Resistance
Tatiana Shaurova, Grace K Dy, Sebastiano Battaglia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 6, 2022
PTEN Loss Expands the Histopathologic Diversity and Lineage Plasticity of Lung Cancers Initiated by Rb1/Trp53 Deletion
Letian Zhang, Congrong Liu, Bo Zhang, et al.
Molecular Cancer Therapeutics
|
September 8, 2018
Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase
Jin H Song, Neha Singh, Libia A Luevano, et al.
Science Signaling
|
November 26, 2024
Coordination between the eIF2 kinase GCN2 and p53 signaling supports purine metabolism and the progression of prostate cancer
Ricardo A Cordova, Noah R Sommers, Andrew S Law, et al.
Frontiers in Oncology
|
January 7, 2025
Small-molecule MMRi36 induces apoptosis in p53-mutant lymphomas by targeting MDM2/MDM4/XIAP for degradation
Rati Lama, Wenjie Wu, Cory K Mavis, et al.
Plos One
|
January 22, 2021
Differential expression of αVβ3 and αVβ6 integrins in prostate cancer progression
Fabio Quaglia, Shiv Ram Krishn, Yanqing Wang, et al.
Molecular Cancer Therapeutics
|
March 5, 2022
A Preclinical Study to Repurpose Spironolactone for Enhancing Chemotherapy Response in Bladder Cancer
Dongbo Xu, Qiang Cao, Li Wang, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 77) with videos related to
Sort By:
Page
of 8
Plos One
|
May 17, 2014
The Thoc1 encoded ribonucleoprotein is required for myeloid progenitor cell homeostasis in the adult mouse
Laura Pitzonka, Sumana Ullas, Meenalakshmi Chinnam, et al.
Cancer Cell International
|
January 8, 2026
Modeling primary immunotherapy resistance in metastatic bladder cancer: a syngeneic, bioluminescent mouse model
Dongbo Xu, Justine J Jacob, Kyle Wieczorek, et al.
The Prostate
|
May 27, 2016
Generation of a C57BL/6 MYC-Driven Mouse Model and Cell Line of Prostate Cancer
Leigh Ellis, ShengYu Ku, Qiuhui Li, et al.
Cancers
|
March 19, 2020
Vitamin D3 Metabolites Demonstrate Prognostic Value in <i>EGFR</i>-Mutant Lung Adenocarcinoma and Can be Deployed to Oppose Acquired Therapeutic Resistance
Tatiana Shaurova, Grace K Dy, Sebastiano Battaglia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 6, 2022
PTEN Loss Expands the Histopathologic Diversity and Lineage Plasticity of Lung Cancers Initiated by Rb1/Trp53 Deletion
Letian Zhang, Congrong Liu, Bo Zhang, et al.
Molecular Cancer Therapeutics
|
September 8, 2018
Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase
Jin H Song, Neha Singh, Libia A Luevano, et al.
Science Signaling
|
November 26, 2024
Coordination between the eIF2 kinase GCN2 and p53 signaling supports purine metabolism and the progression of prostate cancer
Ricardo A Cordova, Noah R Sommers, Andrew S Law, et al.
Frontiers in Oncology
|
January 7, 2025
Small-molecule MMRi36 induces apoptosis in p53-mutant lymphomas by targeting MDM2/MDM4/XIAP for degradation
Rati Lama, Wenjie Wu, Cory K Mavis, et al.
Plos One
|
January 22, 2021
Differential expression of αVβ3 and αVβ6 integrins in prostate cancer progression
Fabio Quaglia, Shiv Ram Krishn, Yanqing Wang, et al.
Molecular Cancer Therapeutics
|
March 5, 2022
A Preclinical Study to Repurpose Spironolactone for Enhancing Chemotherapy Response in Bladder Cancer
Dongbo Xu, Qiang Cao, Li Wang, et al.
Page
of 8